Phibro Animal Health (PAHC) Tops Q2 EPS by 4c, Reaffirms FY17 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Phibro Animal Health Corporation Reports Second Quarter
February 6, 2017 4:15 PM ESTTEANECK, N.J., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its second quarter ended December 31, 2016.
Highlights for the December 2016 quarter (compared to the December 2015 quarter)
Net sales of $192 million, equal to the prior yearNet income of $13 million, a decrease of $16.8 million, or 56%Diluted EPS of $0.34, a decrease of $0.41, or 56%Adjusted EBITDA of $31 million, an increase of $3 million, or 10%Adjusted diluted EPS of $0.39, an increase of $0.02, or 5%ÂCOMMENTARY
We are very... More
